The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"